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A B S T R A C T
Mesoporous silica nanoparticles (MSNPs) have many potential applications in biomedical fields. However, when
MSNPs are exposed to plasma, protein adsorption leads to opsonization and decreases blood circulation time.
A new multifunctional nanodevice based on polyethylenimine (PEI) coated core-shell Fe⁠3O⁠4@SiO⁠2 MSNPs with
a zwitterionic 2-methacryloyloxyethyl phosphorylcholine (MPC) surface was designed to minimize unspecific
protein adhesion. Particle size measurements demonstrated an excellent non-fouling capacity in solutions con-
taining Bovine Serum Albumin (BSA) and Fetal Bovine Serum (FBS) plasma proteins. The system was used in
this study to co-deliver two different cargos: siRNA and daunorubicin. Anti-TWIST siRNA plays critical role in
modulating knockdown of TWIST and sensitizing cells to chemotherapeutics such as daunorubicin for ovarian
cancer therapy. The drug was released in response to externally controlled oscillating magnetic fields (OMF).
siRNA (siGFP) silenced expression of green fluorescence protein (GFP) in Ovcar8 cancer cells, demonstrating
the incorporation of core shell MSNPs into cells and siGFP delivery. The synergistic effect of the co-release of
anti-TWIST-siRNA loaded in the PEI and daunorubicin loaded in NPs’ pores caused increased cytotoxicity in Ov-
car8 of up to 50% from both zwitteronic and non-zwitteronic NPs. The system is the first example of silencing
by anti-TWITS-siRNA/daunorubicin co-delivered using zwitterionic core-shell nanoparticles with low-fouling ad-
sorption. This engineered multifunctional approach may provide therapeutic potential for the treatment of cur-
rently incurable ovarian cancer.
1. Introduction
Silica based mesoporous materials and in particular mesoporosus
silica nanoparticles (MSNPs) have attracted extensive attention due to
their wide spread applications in biomedical fields including biosensing,
drug delivery and diagnostic imaging. They are easily chemically mod-
ified with biomolecules and are used as theranostic agents for biomed-
ical applications [1–5]. The principal requirements for such nanocarri-
ers include safety (non-toxic) and absence of undesirable side-effects.
When nanoparticles (NPs) enter a biological fluid (blood, plasma or
interstitial fluid) they are coated with proteins, the “protein corona”,
that may lead to the exposure of new epitopes, altered function and/
or avidity effects [6]. The protein corona spontaneously forms upon
exposure to proteins and may consist of multiple layers that have dif-
ferent affinities to the NPs surface, e.g. the soft corona consisting of
the external layer of proteins weakly interacting with the NPs, and the
hard corona that strongly adheres to the NPs surface [7]. Because the
protein corona affects the properties of the NPs surface, it has signifi-
cant impact on the interaction between the NPs and cell walls [8–10].
Many studies are described in the literature where NP cellular uptake in-
volves the presence of a protein corona. A key factor affecting their final
uptake rates is their adhesion to the cell membrane [11–14]. In order
to be an effective delivery vehicle, the NPs must have prolonged blood
circulation times and must escape the uptake by mononuclear phago-
cytes, macrophages and the reticuloendothelial systems [12]. The in-
teraction between the positively charged polyethyleneimine (PEI) poly-
mer and the negatively charged proteins might cause a protein corona
effect in this type of nanocarriers. Hence, many PEIs have been chem-
ically modified to decrease the side effect and improve their trans-
fection efficiency [15,16]. An interesting approach to avoid this ef-
fect is the zwitterionization of MSNPs surface for imparting antifoul
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ing properties. Zwitterionic materials are a new class of antifouling sur-
faces that have demonstrated to be efficient due to the formation of a
strong hydration layer through electrostatic interaction. Their weak in-
teractions with serum proteins and their non-toxic nature make them
ideal candidates for gene and drug delivery vectors [17–20].
Ovarian carcinoma is a deadly disease because many patients are
diagnosed in the metastatic stage of the disease and drug resistance is
a major problem [21]. Chemotherapy and surgery are the initial treat-
ment options, but the development of drug resistance is almost univer-
sal. For this reason, much effort has been spent on developing alter-
native therapeutic strategies based on targeted gene therapy in the at-
tempt to exert a cytotoxic action both on the primary tumor and on
the peripheral metastases. In recent years, co-delivery of chemotherapy
drugs and siRNA knockdown target genes to promote anti-tumor ther-
apy has provided a new approach for cancer treatment and has gener-
ated widespread attention [22]. Huang et al. reported that administra-
tion of polymeric nanoparticles able to deliver diphtheria toxin suicide
protein encoding DNA, combined with transcriptional regulation to tar-
get gene expression suppresses ovarian tumor growth and reduces tu-
mor burden [20]. Bai et al. designed cationic heparin-polyethyleneimine
nanogels able to inhibit cell viability by apoptosis induction achieving
a tumor weight reduction of ∼58.55%. [23]. More recently, Roberts et
al. [24] used the protein TWIST as a therapeutic target. TWIST is a de-
velopmental transcription factor reactivated in cancers and linked to an-
giogenesis, metastasis, cancer stem cell phenotype, and drug resistance.
They successfully delivered an anti-TWIST siRNA in combination with
cisplatin from PAMAM dendrimers and PEI coated silica NPs. Their re-
sults revealed a significant impediment of metastatic growth and signif-
icant reduction of the tumor size in animal models of a metastatic and
chemoresistant phenotype.
Another key element in addition to delivering siRNA is the ability
to release anticancer drugs on demand in the desired location after re-
duction of drug resistance [25,26]. External control of the release can
be achieved by using iron oxide superparamagnetic nanoparticles that
generate heat upon exposure to an oscillating magnetic field (OMF) ap-
plication and uncap pores in MSNPs to release the anticancer agent at
a specific rate and site, overcoming the problems of conventional tech-
niques for diagnosis and therapy [27]. The core-shell NPs respond to
oscillating magnetic fields by generating local nanoparticle heating but
the bulk heating effect is negligible, allowing controlled drug delivery
strategies [28]. In this work, we present a proof of concept of a new
smart multifunctional nanocarrier consisting of core shell silica meso-
porous nanoparticles able to avoid unspecific protein adhesion and re-
lease two different cargos, anti-TWIST siRNA and daunorubicin, in re-
sponse to an external oscillating magnetic field.
2. Experimental section
2.1. Synthesis of core-shell Fe⁠3O⁠4@SiO⁠2 mesoporous nanoparticles and PEI
coating
2.1.1. Synthesis and functionalization of the NPs surface with DPTES
Core-shell Fe⁠3O⁠4@SiO⁠2 mesoporous nanoparticles were obtained
through a [29]. Briefly, 1.25mg/L of a chloroform dispersion of super-
paramagnetic iron oxide nanoparticles (SPION, Ocean Nanotech, San
Diego, CA) was added to a 22mL water solution containing 80mg of
CTAB. The mixture was then sonicated for 10min to allow an ho-
mogeneous dispersion of the organic solvent in the water phase af-
ter which the resulting solution was stirred at 85°C to allow the chlo-
roform to evaporate during 10min. Once the solution became clear
the flask was sonicated for 2min to ensure a good dispersion of the
SPION After another 10min at 85°C, 25mg of arginine was added
and finally 200μL of TEOS were added drop by drop. In order to ob-
tain functionalised core–shell nanoparticles, 20μL (2-diethylphospha-
toethyl)triethoxysilane (DPTES) (95wt%, Gelest Inc.) was added to the
mixture after 3h
leading to nanoparticles with phosphonate group on the surface. The
surfactant was removed by ionic exchange soaking nanoparticles in
200mL of a NH⁠4NO⁠3 solution (6g/L) in ethanol at 80°C two times dur-
ing 2h under magnetic stirring. NPs were collected by centrifugation,
washed three times with ethanol.
2.1.2. Zwitterionization of the NPs-PEI surface with 2-
methacryloyloxyethyl phosphorylcholine
The addition of the cationic PEI coating (1.8kDa branched polymer,
Gelest) to the MSNPs has previously been described [30]. In short, ho-
mogeneously suspension of MSNPs was dispersed in PEI ethanolic solu-
tion (2.5mg/mL) which was then sonicated and stirred 30min (repeated
twice). The NPs were then washed in ethanol to remove unbound PEI
leading to NPs-PEI. 1mg/mL of NPs-PEI was mixed in water with 1.2μL
de GA/mg NP glutaraldehyde (GA, 50wt%, Sigma-Aldrich, USA). After
30min. a solution of MPC were added and mixed during 24h at different
MPC/DPTES ratios (x:1), where x=0.25, 0.50, 0.75 and 1, giving rise to
25-MPC, 50-MPC, 75-MPC and 100-MPC zwitterionic NPs, respectively.
Finally, the samples were washed three times with water giving rise to
MPC-25, MPC-50, MPC-75- and MPC-100. h
2.1.3. Characterization of NPs-PEI with and without 2-
methacryloyloxyethyl phosphorylcholine
The morphological study of MSNPs was conducted by transmission
electron microscopic (TEM) experiments using a FEI Tecnai 12 micro-
scope operating at 120kV. The N⁠2-adsorption-desorption isotherms were
measured with a Micromeritics ASAP 2020 instrument (Micromerit-
ics Co, Norcross, USA). The surface area was calculated by the
Brunauer–Emmett–Teller (BET). The pore size distribution was calcu-
lated by Barrett–Joyner–Halenda (BJH) method according to the ad-
sorption branch of the isotherm. ζ-potential and dynamic light scatter-
ing (DLS) measurements were carried out using a Malvern Zetasizer
Nano ZS. Samples were prepared at a concentration of 0.1mg/mL by
dispersing the NPs in 10mM PBS with pH 7.4 at 25°C. Standard de-
viations were calculated with 8 runs. FTIR spectra were recorded on
a Thermo Nicolet 6700 FTIR system. The samples were prepared as
pellets using spectroscopic grade KBr. 1H NMR spectra of the samples
were recorded on a Bruker Avance 300MHz NMR spectrometer using
D⁠2O as the solvent at 25°C. TG measurements were carried out un-
der a dynamic air atmosphere between 25 and 950°C with a heating
rate of 5°C/min using a Perkin-Elmer Diamond analyzer (Perkin-Elmer,
USA). The magnetic properties of zwitterionic and non-zwitterionic
NPs-PEI in a SQUID (MPMS XL-7, Quantum Design) device were carried
out at 300K (Fig. S2).
2.1.4. Antifouling ability evaluation
The anti-fouling ability of the zwitterionic and non zwitterionic NPs
was evaluated in BSA and FBS solutions using dynamic light scattering
(DLS) method. Samples were prepared with ultrapure water at a con-
centration of 0.1mg/mL by dispersing NPs in a 1mg/mL BSA and 10%
FBS solution using ultrasound at pH 7.4. The distribution of diameters
was measured on a Zetasizer (Malvern, UK) before and after incubated
in the BSA and FBS solution for 2, 24 and 72h for NPs-PEI, 25-MPC,
50-MPC, 75-MPC and 100-MPC samples. The mean value was used as
hydrodynamic diameter (Dh).
2.1.5. Loading of core-shell mesoporous nanoparticles with daunorubicin
and dye
Cargo loading was accomplished by soaking the nanoparticles in a
saturated solution of Hoechst 33342 or daunorubicin to fill the meso-
porous structure by diffusion. Containment of cargo in the pores was
achieved by adding PEI coating which electrostatically binds the mole-
cular thread on the phoshponate silica nanoparticle surface. Then, the
nanoparticles were washed thoroughly with water to remove excess
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dye or drug adsorbed on the silica surface. The addition of the cationic
PEI coating to the MSNPs has previously been described [31]. In short,
PEI ethanolic solution (2.5mg/mL) was added to the NPs, then son-
icated and stirred for 30min (repeated twice). The NPs were then
washed in ethanol to remove unbound PEI leading to NPs-PEI.
Prior to the release of the drug in the presence of cells, release mea-
surement test was performed on the NPs applying OMF. 1mg/mL of the
NPs-PEI, 25-MPC, 50-MPC, 75-MPC, 100-MPC samples are dispersed in
PBS, previously loaded with 1mM Hoechst 33342. The release of the
dye was performed at room temperature (RT) and at 50°C in a water
bath between 15 and 360min. Measurements were performed on a spec-
trometer (Spectra Pro 2300i, Acton Research Corporation).
The release of the dye with and without applying the external
OMF stimulus in frequency range of 500kHz with amplitude of up to
37.4kAm⁠−1. Before that, the samples were stabilized for 2h with no
stimuli. Samples are placed inside a water-cooled copper coil which pro-
duced the OMF. The release profiles of Hoechst 33342 from NPs were
monitored at three cycles of 10min (30min) and 6 cycles of 10min
(60min).
2.2. Cell culture test
2.2.1. Cell culture
Ovcar8 were obtained from ATCC and were grown in RPMI 1640
(Genesee Scientific, San Diego, CA) in a tissue culture incubator at 37°C,
5% CO⁠2, and 90% humidity. Growth medium was supplemented with
10% fetal bovine serum and 1% penicillin/streptomycin. Cells were pas-
saged every 2–4days using 0.25% trypsin (Genesee Scientific). Cells
were passaged every 2–4days using 0.25% trypsin (Genesee Scientific).
To allow for imaging of cells, we created a line of Ovcar8 that stably ex-
pressed GFP and firefly luciferase (ffluc). These cells were created with
the aid of a CMV lentiviral construct that encodes a fusion protein of
GFP and ffluc separated by a three glycine linker. This stable cell line
was used for all experiments.
2.2.2. Fluorescence microscopy
We determined the time it takes NPs are internalized in the cells.
For this purpose we load the NPs with a siRNA marked with Alexa647.
After that 2.5·10⁠4cells/mL were seeded in a 6-well plate the day prior
to incorporation of the NPs. At the same time, 70μl of the nanoparti-
cles were loaded into 10μL of siRNA-Alexa647 (Qiagen, Valencia, CA)
and 20μL of free RNAases water (Fisher Scientific, USA) were washed
tree times with PBS after12h and fixed by 70% ethanol for 15min. The
cells were observed with a fluorescence microscope (Nikon, Nikon In-
struments Inc.). Cells in green (450/510 excitation/emission) and red
NPs loaded with siRNA-Alexa647 (650/665 of excitation/emission).
2.2.3. eGFP gene silencing and transfection
Ovcar8 cells were seeded in 6-well plates at a seeding density of
3.5·10⁠3cells/mL 24h prior to the experiment. In parallel 70μL of
nanoparticles were loaded with 10μL siRNA or (Dharmacon™ Accell™
eGFP Control siRNA, USA) and 20μL RNAase free water (Fisher Scien-
tific, USA) and mixed for 15h. Then, 100μL of NPs-siGFP (siRNA against
eGFP) were added to cells and incubated at 37°C and 5% CO⁠2 during
1, 2, 3 and 4days. The medium was changed 24h of the addition of the
NPs and every two days of the trial. The cells with siGFP were observed
in a fluorescence microscope (Nikon, Nikon Instruments Inc.) with a
wavelength of 410nm excitation and emission of 510nm.
2.2.4. Cargo and release of daunorubicin: Cell viability test
Ovcar8 cells were seeded in 8-well plates at a seeding density of
3.5·10⁠3cells/mL 24h prior to the experiment. In parallel, 17.5μL of
concentration 1 (17.5μg/mL NPs) and 35μL of concentration 2
(35μg/mL NPs) were prepared. 10mg NPs were previously loaded with
2mL of daunorubicin in ethanol (1mM) in dark overnight, washing
three times followed of PEI and/or MPC functionalization as previously
described. The amount of loaded daunorubicin was 8±2%, determined
by TG. The culture medium was changed after 24h of incubation and
three cycles of 10min (30min) and 6 cycles of 10min (60min) applied
to the cells of an oscillating magnetic field (375kHz, 20kAm⁠−1) at RT.
2.2.5. Zwitterionic and non zwitterionic NPs with anti-TWIST-siRNA
(si419): Cell viability test
Previously published siRNA sequences against TWIST (si419-pas-
senger, 5′-GACAAGCUGAGCAAGAUU-3′; si419-guide, 5′-AAUCU-
UGCUCAGCUUG UCCUU-3′; si494-passenger, 5′-GCGACGAGCUG-
GACUCCAA-3′; si494-guide, 5′-UUGGAGUCCAGCUCGUCGCUU-3′)
were used [30]. Two chemical modifications (addition of 2′-O-methyl
and inverted abasic ribose) were made to the si419 passenger/sense
strand for all experiments. No chemical modifications were made to
the si494 sequences. siRNA duplexes were formed by mixing equal mo-
lar volumes of each strand together and heating them in a hot block
(100°C) for 10min, then removing the block from the heat source to
cool to RT. Negative control siRNA (siQ, labeled with AlexaFluor®647)
was All Stars Negative Control siRNA from Qiagen (Valencia, CA). There
were assay five different conditions with NPs-PEI, 50-MPC and 75-MPC:
control NPs (NPs), siRNA loaded in NPs as negative control (siQ), NPs
loaded with anti-TWIST-siRNA (Si419 and daunorubicin without OMF
(Si419-Dau), NPs loaded with Si419 and daunorubicin with OMF
(Si419-Dau⁠∗) and two dosis of NPs loaded with Si419 the first one and
NPs loaded with daunorubicin the second one with OMF with the same
final NPs amount (Si419-Dau⁠∗-TS). Transfection of siRNA with zwit-
terionic and non zwitterionic NPs was carried out by incubating the NPs
with the siRNA overnight at 4°C while rotating the tube constantly. The
mixture consisted of a similar protocol of eGFP gene silencing with 35μL
diluted from 0.5mg/mL and using Si419 diluted in free RNAase water
mixed during 15h. The final concentrations of NPs and siRNA applied
to cells were 35ng/μl and 100nM, respectively. Following Roberts CM
et al. protocol [24] NPs were added to cells and were incubated at 37°C
and 5% CO⁠2 during 7d. The media were changed after 24h of incorpo-
rating zwitterionic and non zwitterionic NPs and each three days of as-
say. A second dosis of Dau charged NPs were added after 5days of as-
say in Si-TWIST-Dau⁠∗ plate. OMF were applied in Si-TWIST-Dau⁠∗ and
Si-TWIST-Dau⁠∗ (two steps) samples. The plate was placed inside a wa-
ter-cooled copper coil which produced an OMF with the same above
conditions. The culture medium was changed after 24 h of incubation
and three cycles of 10min (30min) and 6 cycles of 10min (60min) ap-
plied to the cells of an OMF (375kHz, 20 kA m⁠−1) at RT. Mitochondrial
activity of cells in contact with NPs was measured using the 3-[4.5-di-
methylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) test. The
MTT assay is based on the activity of mitochondrial dehydrogenases of
living cells that reduces yellow MTT to blue formazan, and the colored
solution is measured spectrophotometrically at 570nm. Following this
incubation period media was removed from each well and 110μL MTT
diluted in complete media (0.45mg/mL) was added. Incubation lasted
for 3h at 37°C, 5% CO⁠2, with 90% humidity. Following the incubation
period the MTT media was removed and 110μL DMSO was added to
each well and the plate was gentle shaken for 15min. Statistical compar-
isons were made by analysis of variance (ANOVA). The Scheffé test was
used for post hoc evaluation of differences between groups. In all statis-
tical evaluations, p<0.05 was considered as statistically significant.
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3. Results and discussion
3.1. Characterization of core-shell Fe⁠3O⁠4@SiO⁠2 MSNPs
The synthetic protocol is shown in Fig. 1. Core-shell Fe⁠3O⁠4@SiO⁠2
mesoporous nanoparticles functionalized with DPTES (negatively
charged), were grafted with the cationic polymer PEI (1.8kDa branched
polymer), to ensure siRNA in MSNPs [32]. Subsequently, the PEI was
crosslinked with GA give rise to an imine Schiff base, avoiding degrada-
tion of Fe⁠3O⁠4@SiO⁠2 NPs-PEI in the next step in water media (Fig. S1). Fi-
nally, functionalization of amine from PEI by Michael addition reaction
with biomimetic MPC monomer was performed [33]. The partial func-
tionalization of PEI give rise to NPs with zwitterionic fragments named
as 25-MPC, 50-MPC, 75-MPC and 100-MPC zwitterionic NPs. TEM im-
ages show monodispersed NPs before and after covering with PEI and
MPC functionalization (Fig. 2A). The zwitterionic and non zwitterionic
NPs exhibit a ∼70nm diameter with a Fe⁠3O⁠4 core of 20nm. DLS analy-
sis showed an average hydrodynamic size of a ∼74nm and ∼125nm
without and with PEI in PBS, respectively. Bare NPs exhibits a negative
ζ-potential (−31.2mV) and after PEI coating resulted in particles with
a positive ζ-potential of +24.5mV in PBS.
Textural properties of the MSNPs have been performed by N⁠2 ad-
sorption/desorption analyses (Fig. 2B). Similar behaviour was obtained
in all NPs (Table 1). The isotherms of NPs-PEI, MPC-100 and calcined
MPC-100 samples were plotted as a representative example. They can
be identified as type IV according to the IUPAC classification, which
are typical of mesoporous solids [34]. The presence of H1 type hystere-
sis loops in the mesopore range indicates the existence of open ended
cylindrical mesopores with narrow pore size distributions [35,36]. The
surface area (S⁠BET) experienced an increase when the samples are cal-
cined at 600°C indicating the previous coverage and after calcination,
the maintenance of mesoporosity after the PEI and MPC functionaliza-
tion for MPC-100. A spherical silica structure with a radial orientation
and open pores about ∼1–2nm in diameter were obtained. Pore vol-
ume, pore diameter and surface area displayed a progressive decrease
from NPs functionalized with PEI and for all zwitterionic NPs which is
in agreement with the appropriate successively functionalization of NPs
and the increase of S⁠BET when the samples are calcined indicating the
maintenance of mesoporosity, as was expected (Table 1).
The chemical structures of NPs-PEI with and without MPC were
identified with Fourier transformation infrared spectroscopy (FTIR) and
the results are shown in Fig. 2C. FTIR spectra for the bare NPs ex-
hibiting bands of Si O at 1050, 802 and 470cm⁠−1. Characteristic
peaks of PEI at 3272cm⁠−1 ( N H stretching), 2940–2830cm⁠−1 (
C H stretching), 1576cm⁠−1 ( N H bending), 1465cm⁠−1 ( C
H bending) and 1350–1000cm⁠−1 ( C N stretching). Unlike PEI,
the FITR spectrum of polyamine microspheres displays a distinct peak
at 1650cm⁠−1, which is the stretching band of C N, indicating
the Schiff reaction between the amine groups of PEI and the alde-
hyde groups of glutaraldehyde. It should be noted that the presence of
water molecules also result in the appearance of an absorption peak
at 3424cm⁠−1 [37]. Zwitterionic NPs exhibiting bands at 1718, 1242,
1078 and 970cm⁠−1 corresponding to (C O), (O P O ), (P
O C) and ( N+ (CH⁠3)⁠3 ) respectively, indicating the function-
alization of NPs with MPC. Moreover, no signals at 1321cm⁠−1 (C
C), 1298cm⁠−1 (C C) indicate the absence of methacrylic C C dou-
ble bonds so the anchoring (not adsorption) of MPC can be confirmed.
[38,39]. The 1H-NMR spectra for MPC product, zwitterionic and non
zwitterionic samples are shown in Fig. 2D. Signals between 2.5 and
3.2ppm correspond to PEI polymer. Signals at 1.89, 5.77 and 6.15 rela-
tive to C C bond of MPC product indicating an anchored to PEI-NPs.
MPC 1H NMR (300MHz in D2O): d (ppm)=1.89 (s; CH⁠2 CHCH⁠3 6H),
3.1 (s; N⁠+(CH⁠3)⁠2 6H), 3.74 (m; CH⁠2 2H), 3.86 (m; CH⁠2
2H), 4.15 (m; CH⁠2 2H), 4.32 (m; CH⁠2 2H), 4.38 (m; CH⁠2
2H), 4.65 (m; CH⁠2 2H), 5.74 (m; CH CHCH⁠3 1H), 5.77
(m; CH CHCH⁠3 1H), 6.16 (m; CH CHCH⁠3 1H). The amount
of PEI and MPC anchored in the surface of NPs were determined by
TG analyses. The results reveal a 23.8% of PEI in NPs-PEI, 0.5% of GA
and a progressive increase of MPC for 25-MPC, 50-MPC, 75-MPC and
MPC-100 samples (Table 1). In addition, the results obtained by TG
measurements revealed that there were different weight losses between
materials before and after MPC functionalization. Thus, the successful
immobilization of MPC on the nanoparticles has been confirmed.
3.2. Antifouling ability evaluation
It is known that proteins adsorbed onto the surface of biomaterials
can trigger thrombosis and blood coagulation, leading to life-threaten-
ing situations or causing functional failure when biomaterials are used
Fig. 1. Synthesis scheme of zwitterionization of NPs-PEI.
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Fig. 2. A. Characterization by Dinamic Light Scattering and ζ-potential of NPs and NPs-PEI. B. N⁠2 adsorption isotherms surface area and pore size of NPs and NPS-PEI, 100-MPC-calcined
and 100-MPC. C. FTIR bands zwitterionic and non-zwitterionic of MSNPs D. H-NMR spectrum of PEI-MPC with varied graft ratios (in D⁠2O).
Table 1
Textural properties derived from N⁠2 sorption measurements for bare MSNPs, NPs-PEI and
MPC NPs before calcination and calcinated (CAL).
Sample
S⁠BET
(m⁠2/g)
V⁠T
(cm⁠3/g)
D⁠P
(nm)
%
PEI
(TG)
%
MPC
(TG)
NPs-PEI
(CAL)
964 1.12 2.5 – –
NPs-PEI 250 0.60 1.2 23.8 –
MPC-25 205 0.58 0.9 23.8 3.5
MPC-25
(CAL)
640 0.87 2.1 – –
MPC-50 204 0.55 0.9 23.8 7
MPC-50
(CAL)
630 0.85 1.8 – –
MPC-75 191 0.54 0.9 23.8 12
MPC-75
(CAL)
652 1.1 1.8 – –
MPC-100 194 0.47 1.1 23.8 16
MPC-100
(CAL)
638 0.90 1.9 – –
S⁠BET is the total surface area determined by the BET method between the relative pressures
(P/P⁠0) 0.05–0.25. V⁠T is the total pore volume obtained using the t-plot method. D⁠P is the
pore diameter calculated by means of the Barrett-Joyner-Halenda (BJH) method from the
adsorption branch of N⁠2 isotherm. The percentage of functionalization with PEI and later
MPC incorporation was estimated from thermogravimetric (TG) measurements.
in artificial organs, blood vessels, and other medical devices in con-
tact with blood. This undesirable interaction with non-specific protein
adsorption is among the first events that occur at the interface be-
tween carrier and human blood [40]. To have a better understanding on
how the amino and phosphate groups from MPC will affect anti-fouling
properties of NPs-PEI, their anti-fouling property was evaluated in pro-
tein solutions using DLS measurements.
First of all, the stability of the samples in PBS was tested. All the NPs
are stable up to 3days, more than enough time to be internalized by
the cancer cells after being administered (Fig. 3). After protein non-spe-
cific adsorption occurs, the Dh of NPs will increase. A single compo-
nent BSA solution was first used because albumin is the most abun-
dant protein in serum. In addition, to mimic the complex biological sys-
tem, NPs were incubated in the FBS solution and the DLS was mea-
sured. Before carrying out the BSA study, the ζ-potential of samples
were measured in water to estimate the total relative charge of zwitte-
rionic and non zwitterionic NPs-PEI in PBS. The ζ-potentials were posi-
tive for all of the NPs, as expected because of the presence of secondary
and primary amino groups from the PEI polymer. Moreover, all MPC
functionalized NPs presented a positive charge due to their zwitterionic
nature and the PEI amino groups. 75-MPC and 100-MCP samples ex-
hibited a slight ζ-potential decrease due to a higher zwitterionization
(Fig. 3 and Table 1). The ζ-potentials of BSA and FBS were also mea-
sured and had a negative charge, indicating that an electrostatic attrac-
tion to PEI-derivatized NPs should be favourable. In DLS particle sizes
remained stable over time in the 50-MPC, 75-MPC and 100-MCP NPs
compared to NPs-PEI and 25-MPC samples over time. In NPs-PEI and
25-MPC samples the size increased over time to 340 and 220nm in FBS
solution and up to 225 and 200nm respectively in BSA solution. In BSA
their size is less than 130nm after 72h. 50-MPC, 75-MPC zwitterionic
NPs sizes were maintained at 170nm in FBS solution (Fig. 3). Thus the
most suitable samples to avoid nonspecific protein adhesion and thus
would avoid opsonization of NPs in the bloodstream were 50-MPC and
75-MPC. This phenomenon can probably be attributed to the strong
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Fig. 3. Evolution of hydrodinamic diameter of 0.1mg/mL of NPs-PEI, 25-MPC, 50-MPC, 75-MPC and 100-MPC with soaking in 1mg/mL BSA and 10% FBS solution. Evolution of hydrod-
inamic diameter of 1mg/mL of all NPs in PBS. ζ-potential of BSA, FBS, zwitterionic and non zwitterionic NPs.
surface hydration layer formed by the neutral zwitterionic structure.
These results indicate protein corona formation around 50-MPC,
75-MPC is inhibited in BSA and FBS media.
3.3. In vitro cargo release experiments
The application of an OMFcauses heating of the iron oxide nanocrys-
tal’s core. Thus, prior to studying the release of the drug in the pres-
ence of cells, we performed a series of release measurements on NPs
as a function of temperature. For that study, 1mg/mL of the NPs-PEI,
25-MPC, 50-MPC, 75-MPC, 100-MPC in PBS samples are dispersed.
The samples were washed multiple times to remove dye from the
surfaces until the washings were free of dye. The measurements of
the Hoechst dye release were made between 15 and 360min at RT
and with external stimulus. It is observed that in samples with GA
crosslinked PEI and zwitterionization with MPC the release of Hoechst
to the medium is faster from zwitterionic NPs when the temperature is
applied (Fig. 4) as it will be explained later. Dye release data showed
in Fig. 4A can be fitted to a first-order kinetic model with an empirical
nonideality factor (δ) (Eq. (1)) [41]:
(1)
where Y is the percentage of dye released at time t, A the maximum
amount of dye released (in percentage), and k, the release rate con-
stant. The values for δ are 1 for materials that follow first-order kinet-
ics, and 0, for materials that release the loaded drug in the very initial
time of analysis. The kinetic fitting indicates that, while the maximum
amount of Hoechst released is practically the totality of the loaded dye
after 360min of temperature application, most of the cargo is retained
without the external stimulus (>62%) for 50-MPC and 75-MPC zwitte
Fig. 4. (A) Hoechst 33342 release from NPs-PEI, 50-MPC and 75-MPC in PBS solution versus time with external stimuli temperature. (B) Kinetic model of cargo release from zwitterionic
and non zwitterionic NPs at room temperature and 50°C.
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rionic NPs. Since δ gives an approximation of the degree of fidelity of
the proposed model to the theoretical first-order kinetics, when δ is
smaller the first-order is less accurate and the delivery of the drugs from
mesopores shows a larger burst effect. This latter effect is usually attrib-
uted to the adsorption of drug molecules on the outermost surface of the
mesopores. As it can be seen in Fig. 4B, the values of δ are larger for
Hoechst release at RT than at 50°C. In addition, the maximum percent-
age of delivered from NPs (Y), goes up to 83–89%, reached in the first
6h with the external stimulus from MPC-50 and MPC-75, respectively.
The reduction of the drug release amount in NPs-PEI is attributed to the
partial retention of drug molecules onto the mesopores due to higher
electrostatic repulsions between cargo and positively charged PEI as we
explain immediately above.
3.4. In vitro cargo release assays by OMF
The release profiles caused by magnetic heating were studied by
monitoring the fluorescence of the released dye from aliquots of the so-
lution taken at different time points (Fig. 5). The cuvette containing the
particles was placed inside a 5-turn coil and an oscillating magnetic field
(375kHz, 20 kA m⁠−1) was applied. The first three points in the graph
correspond to equilibration before magnetic activation, showing mini-
mal dye leakage. After 2h, three cycles of 10min (30min) and 6 cy-
cles of 10min (60min) and 1min/cycle heating off were applied; the
Fig. 5. Hoechst 33342 release from NPs-PEI, 50-MPC and 75-MPC in PBS solution versus
time with external stimuli oscilating magnetic field (OMF) (A). Samples are placed inside a
water-cooled copper coil which produced an oscilating magnetic field (OMF) in frequency
range of 500kHz with an amplitude of up to 37.4kAm⁠−1 after 2h with no stimuli. (B) Re-
lease profiles of Hoechst 33342 from NPs at 30 and 60min of OMF.
cooling cycle was used to minimize overheating the bulk solution, mon-
itoring the temperature each 10min (not higher than 37°C) (Fig. 5A).
For therapeutic applications, it is important to take into account that,
although the system has no specific functionalization for OMF stimuli,
the GA crosslinking and MPC anchored to PEI reveal a different behav-
iour between NPs-PEI and zwitterionic MPC-50 and MPC-75 NPs. Al-
beit, when OMF stimulus is applied at 30 and 60min. significatively
increase of cargo is released from MPC-50 and MPC-75 NPs. The re-
lease after 60min of OMF cycle was 14% and 23% higher in MPC-50
and MPC-75 NPs compared to NPs-PEI (Fig. 5B). Thus, during the OMF
stimulus cycles a higher amount of dye release from zwitterionic NPs.
Similar behaviour was observed when temperature stimulus is applied
to NPs in Fig. 4. The daunorubicin is an anthracyclines as doxorubicin.
They have the same amino sugar moiety daunosamine, with pK of 8.4
so it is positively charged at physiological pH as well as the cationic
dye, Hoechst 33342 (pKa=11.9). Therefore, these cargos are attracted
to negatively charged surfaces where both agents could be released by
dropping the environmental pH. Thus, the load of cargo in negatively
charged phosphonate NPs (pKa=2) was enhanced compared to silica
NPs (pKa=7), which is near to its isoelectric point and therefore not
quite as effective for electrostatic binding [42]. The electrostatic re-
pulsion with cationic PEI provoke a slower release from NPs-PEI com-
pared to zwitterionic NPs. Since hydrophobic interactions increase and
positively repulsions decrease when PEI was cross-linked with GA and
zwitterionizated in case of MPC-50 and MPC-75 NPs, so the release of
cargo is significantly higher after OMF stimulus was applied. Gawde
et al. observed a similar behaviour when a higher drug release rate
in glutaraldehyde-crosslinked albumin bio-conjugate nanoparticles sys-
tem. [43]. Dmour et al. [44] investigated the potential to stabilize chi-
tosan based NPs prepared by ionotropic gelation method by covalent
crosslinking using a dimethylaminopropyl-carbodiimide as a coupling
agent and observed that the release of doxorubicin was enhanced upon
loading in covalent crosslinked NPs compared to free doxorubicin.
3.5. Internalization assay
In vitro cellular uptake experiments were performed using Ovcar8
cells and zwitterionic and non zwitterionic NPs (Fig. 6A). To identify
the final fate of the internalized nanoparticles, a fluorescence imaging
study was carried out by fluorescence microscopy. The uptake of the
NPs was evaluated after 12h cell culture, and is shown in Fig. 6A. As has
been demonstrated, the cationic polymer PEI could facilitate nanopar-
ticle uptake in some extent, so NPs-PEI is a control in the test [45].
Red Alexa647 labelled siRNA loaded in the NPs and the eGFP transgene
green fluorescence properties in Ovcar8 cells was chosen for our inter-
nalization in vitro experiments. The orange spots derived from localized
nanoparticles (red) in endolysosomes (green) were noticeable for zwit-
terionic and non zwitterionic NPs. Thus, labelled siRNA loaded in NPs
remain on the NPs and the NPs were internalized after 12h of exposure.
3.6. eGFP gene silencing and transfection
It was of great importance to provide evidence of activity of the
siRNA inside cells and determine the efficacy of zwitterionic NPs as
siRNA carriers. The eGFP transgene was chosen for our initial in vitro
experiments because eGFP’s fluorescence properties facilitated analysis
of silencing efficiency [31].
To visualize the transfection effect, the eGFP expression in Ov-
car8 cells was observed using fluorescence microscopy (Nikon). Fig. 6B
shows some typical fluorescence images of ovarian cancer cells trans-
fected by NPs-PEI, MPC-50 and MPC-75. As can be seen all NPs loaded
with siRNA against eGFP gene caused a dramatic decrease in the num-
ber of fluorescent Ovcar8 cells after 4days compared to 1day. These
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Fig. 6. (A) Fluorescence microscopy images of eGFP expressing Ovcar8 cells incubated with NPs loaded with siRNA-labeled with Alexa647. From left to right: Green fluorescence of
eGFP-expressing Ovcar8 cells; Red fluorescence (Alexa647-siRNA-NPs) of internalized NPs and overlay images of the two fluorescence channels after 12h. (B) Images of NPs-PEI, 50-MPC
and 75-MPC mediated eGFP silencing with fluorescence microscopy. Untreated Ovcar8 cells as a negative control (control) and eGFP-expressing Ovcar8 cells with NPs after 1 and 4days.
results demonstrate that both zwitterionic and non zwitterionic
nanocarriers are able of sequestering and protecting siRNA, carrying
it into cells and silencing the target gene expression of the exogenous
green fluorescent protein of ovarian cancer cells.
3.7. Cell viability evaluation
3.7.1. In vitro cytotoxicity assay
First, Ovcar8 cells were seeded in 8-well Chamber Slide™ system
(Nunc® Lab-Tek) at a seeding density of 3.5·10⁠3cells/well 24h prior to
the experiment. We assessed the cytotoxicity of NPs-PEI, MPC-50 and
MPC-75NPs with and without daunorubicin (Dau) at 17.5μg/mL (1)
and 35μg/mL (2) of NPs applying 30 and 60min of OMF external stim-
ulus (Fig. 7A). In presence of the OMF, the local heating caused by
the magnetic NPs, facilitated the release of Dau from the silica pores
and thus decreases proliferation of ovarian cancer cells. The cytotoxi-
city was similar for 30min and 60min of OMF cycles in NPs-PEI and
MPC-50. MPC-75 NPs exhibit significantly higher cytotoxicity behav-
iour at 35μg/mL NPs with 60min of OMF and compared to NPs-PEI and
MPC-50, due to the release of cargo in this system was higher after two
cycles of OMF (Fig. 7A). Thus, the zwitterionic NPs exhibited at least
similar cytotoxicity compared with non zwitterionic NPs-PEI with a cell
death between 20 and 30%. The effect of the OMF on the cells was ex-
amined without drug loading under the same conditions as a control.
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Fig. 7. Results of Ovcar8 cell proliferation after exposure to siRNA and/or Dau with or without OMF. (A) Fluorescent microscope images of cells after 60min of OMF without NPs and
with 35μg/mL of NPs-PEI, 50-MPC and 75-MPC. Proliferation assay after 30 and 60 min of OMF with 17.5 μg/mL (1) and 35μg/mL (2) of zwitterionic and non zwitterionic NPs. y(B)
Comparison of the cytotoxic effects of different co-delivery modalities of siRNA and/or Dau in Ovcar8 cells by MTT assay. ⁠⁠t The Ovcar8 cells were treated by 35 μg/mL of NPs using NPs,
SiQ, Si419-Dau, Si419-Dau* and Si419-Dau*-TS conditions assay (*). Data were expressed as the mean±SEM of three independent experiments(⁠*≠p>0.05).
When these NPs were endocytosed into the cells and exposed to the
OMF, no significant cytotoxicity was observed.
3.7.2. Co-delivery efficacy of the siRNA and daunorubicin loaded NPs in
vitro
Since we demonstrated a higher or similar killing cancer cells at
60min of OMF and 35µg/mL of zwitterionic and non zwitterionic NPs,
we tested the toxicity of co-delivery of anti-TWIST siRNA (Si419) and
Dau from the NPs in these conditions (Fig. 7B). To evaluate the effects of
both Si419/Dau co-delivery and an active targeting strategy on the cy-
totoxicity in Ovcar8 cells, the cytotoxicities of the zwitterionic and non
zwitterionic NPs loaded with both Si419/Dau and applying or not OMF
was measured by MTT assay after 7days (Fig. 7B). NPs-PEI, MPC-50 and
MPC-75 in Si419-Dau and Si419- Dau⁠∗ conditions induced a similar de-
crease in cell viability in Ovcar8 cells and significantly higher cytotox-
icity compared to controls of NPs and siQ conditions. These NPs and
siQ conditions should not exercise any cytotoxic effect due to they are
negative controls. Moreover, MPC-50 and MPC-75 NPs with Si419-Dau⁠∗
conditions all markedly decreased up to 50% the cell viability com-
pared to controls, indicating a significant synergetic effectiveness
for the combination of siRNA and Dau. Thus, the siRNA/Dau combined
treatment delivered with OMF by zwitterionic MPC-50 and MPC-75 NPs
produced significantly higher cytotoxicity than the same with no OMF
(Si419-Dau) and the system in two steps (Si419-Dau⁠∗-TS). This system
was not so effective since the two separate doses (17.5µL NPs/dose)
with five days of difference did not have the same killing effect than
the synergic Si419-Dau⁠∗ conditions. Furthermore, the cytotoxic effect
was up to 20% higher compared to zwitterionic and non zwitterionic
NPs loaded only with Dau. The proposed mechanism of the NPs acti-
vation could be mediated by the increased cellular accumulation due
to the potential of PEI to enter the lysosomal compartment. The ‘pro-
ton sponge’ nature of PEI is thought to lead to buffering inside endo-
somes. Nanoparticles coated with polycationic polymers can deliver an-
ticancer drugs and/or DNA/siRNA into the cytosol, based on the en-
dosomal escape mechanism to achieve tumor static effects. The addi-
tional pumping of protons into the endosome, along with the concur-
rent influx of chloride ions to maintain charge neutrality, increases
ionic strength inside the endosome. This effect then causes osmotic
swelling and physical rupture of the endosome, resulting in the escape
of the vector from the degradative lysosomal trafficking pathway [6]. It
Fig. 8. Schematic of the proton sponge effect leading to lysosomal damage and induction of cytytoxitity with co-delivery siRNA and daunorubicin by multifunctional zwitterionic nanopar-
ticles.
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is worthy to note that zwitterionic NPs maintained that properties af-
ter MPC functionalization. These results are agree with the findings of
several authors that have demonstrated better transfection efficiency
modifying low molecular weight PEI with a hydrazone-based crosslinker
[16,17,46].
In summary, these NPs have been designed for a multiple function
as co-delivery of chemotherapy drug and metastasis related gene silenc-
ing siRNA to enhance cancer therapy (Fig. 8). This proof-of-concept of
proposed multifunctional nanocarriers designed to kill ovarian cancer
cells substantially enhances efficiency of chemotherapy with low-foul-
ing properties.
4. Conclusion
In this work, a proof of concept of a new smart multifunctional
nanoparticles able to decrease unspecific protein adhesion and release
two different cargos, siRNA and daunorubicin, in response to external
stimuli, such as oscillating magnetic field, has been presented. To our
knowledge, this research represents the first example of silencing by
siRNA co-delivered with Dau using zwitterionic core-shell nanoparticles
with resistance to nonspecific protein adsorption. Thus, this combina-
torial approach may provide therapeutic potential for the treatment of
ovarian cancer to translate these in vitro results to clinical applications.
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